Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 2186820)

1.

Characterisation of a novel Fc conjugate of macrophage colony-stimulating factor.

Gow DJ, Sauter KA, Pridans C, Moffat L, Sehgal A, Stutchfield BM, Raza S, Beard PM, Tsai YT, Bainbridge G, Boner PL, Fici G, Garcia-Tapia D, Martin RA, Oliphant T, Shelly JA, Tiwari R, Wilson TL, Smith LB, Mabbott NA, Hume DA.

Mol Ther. 2014 Sep;22(9):1580-92. doi: 10.1038/mt.2014.112. Epub 2014 Jun 25.

2.

Anti-GD2 antibody therapy for GD2-expressing tumors.

Navid F, Santana VM, Barfield RC.

Curr Cancer Drug Targets. 2010 Mar;10(2):200-9. Review.

3.

Immune therapies for neuroblastoma.

Navid F, Armstrong M, Barfield RC.

Cancer Biol Ther. 2009 May;8(10):874-82. Epub 2009 May 9. Review.

4.

CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.

Fischer-Smith T, Tedaldi EM, Rappaport J.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):417-21. doi: 10.1089/aid.2007.0193.

5.

Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.

Bourgin C, Bourette RP, Arnaud S, Liu Y, Rohrschneider LR, Mouchiroud G.

Mol Cell Biol. 2002 Jun;22(11):3744-56.

6.

Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

Fingerle-Rowson G, Angstwurm M, Andreesen R, Ziegler-Heitbrock HW.

Clin Exp Immunol. 1998 Jun;112(3):501-6.

7.
8.

Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.

Rosenfeld ME, Ylä-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D.

Am J Pathol. 1992 Feb;140(2):291-300.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk